Pharmadent, LLC

Novel US Patent Topical Anesthetic for multiple medical fields including dentistry, oncology, dermatology, OTC, sports medicine

  • Stage Full Product Ready
  • Industry Healthcare Services
  • Location Bethalto, IL, USA
  • Currency USD
  • Founded January 2012
  • Employees 2
  • Incorporation Type LLC

Company Summary

Company recently formed to hold the US patent ( 8,263,047) for exclusive licensure to a reputable company willing to acquire the pharmaceutical compound for marketing in the US. The company holds additional patents pending worldwide with additional filings expected in the future.

Team

  • Dr. Alan J Wickenhauser
    co-founder

    practicing general dentist over 14 years, holder of US patent, opinion leader panel for Coltene Whaledent, lecturer, writer for national dental journal.

  • Stephen E Peipert, RpH
    co-founder

    compound pharmacist over 30 years, holder of US patent, advisory panel for Southern Illinois University School of Pharmacy

  • Dr. Robert Lake
    Regulatory Director

    recently retired, previous employment as the regulatory director for St. Judes Childrens Research Hospital; Memphis,TN.

  • Dr. Kevin Rowland
    Chief Researcher (clinical and preclinical)

    Professor of Physiology at Southern Illinois University School of Dental Medicine; Alton, IL. Extensive research in the subject of pain, nerve receptors. Published articles for patented topical.

Advisors

  • Grace Fishel, patent attorney
    Lawyer
    Unconfirmed
    Charles Tzinburg, CPA
    Accountant
    Unconfirmed

Previous Investors

  • no previous investors
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free